November 27, 2015
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 27, 2015
EU opens door for Impax’s Parkinson’s treating oral capsule Numient
Impax Laboratories has been granted by the European Commission (EC) authorization to market its Numient oral capsule formulation for the symptomatic treatment of adult patients with Parkinson’s disease.
November 27, 2015
No revenues for Kiadis Pharma in the first 9 months 2015
Kiadis Pharma did not generate any revenues in the first nine months of 2015, the company said Friday.
November 27, 2015
(Edited) RPG Life Science calms down investors. Says media writings are premature
RPG Life Science Limited has said that the media reports which said that “RPG Life Plans Skincare Foray, May Roll Out Biz Next Month” came out premature.
November 27, 2015
WHO records highest-ever number of new HIV cases in its European Region
The World Health Organisation (WHO) said on Thursday that in 2014 it had recorded the highest number of new HIV cases in its European Region, which also includes Central Asia, since the start of reporting in the 1980s.
November 26, 2015
GSK in China – escaping the shadow of a scandal
GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014.
November 26, 2015
Sinclair IS Pharma going aesthetic
Sinclair IS Pharma plc will sell its non-aesthetics business to Alliance Pharma plc for £132m
November 26, 2015
FDA may withhold approval of Dr. Reddy’s new applications or supplements listing
The FDA said that, until Dr. Reddy’s complete all corrections and FDA confirms its compliance with CGMP, it may withhold approval of any new applications or supplements listing Dr. Reddy as a drug product or API manufacturer.
November 26, 2015
NICE recommends drugs to treat 4 different medical conditions
The National Institute for Health and Care Excellence (NICE) has published its final recommendations on whether six different drug treatments…
November 26, 2015
LEO Pharma appoints Svend Andersen EVP head of Europe+
LEO Pharma has named Svend Andersen as incoming EVP, Head of Region EUROPE+, who will assume the position of Executive Vice President, Head of Region EUROPE+, on January 1, 2016. He will join LEO Pharma’s Executive Leadership Team and report directly to the CEO.